AbbVie Inc (NYSE:ABBV)

During the Trading Day
58.71 -0.35 / -0.59%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
58.71 0.00 / 0.00%
 
Volume: 313.1K
Surprising Silver Lining for Gilead Sciences, inc. Stock
3:38pm / MotleyFool.com
Abbott Labs (ABT) to Repurchase Shares for $3B - Analyst Blog
Sep 12 / Zacks.com
3 Partnerships Pushing The Pharmaceutical Sector Forward
2:04pm / Benzinga
Biogen Reports Positive Two-Year Data on MS Drug Plegridy - Analyst Blog
Sep 12 / Zacks.com
3 Stocks Pulling The Drugs Industry Downward
1:15pm / TheStreet.com
Seattle Genetics-Genmab Expand Deal for Antibody Platform - Analyst Blog
Sep 11 / Zacks.com
AbbVie (ABBV) Declares 42c Quarterly Dividend
Sep 19 / TheStreet.com
Google Acquires Maker of Biotech Hardware, Lift Labs - Analyst Blog
Sep 11 / Zacks.com
Dividend Aristocrats: Time to Buy AbbVie Inc Stock?
Sep 19 / MotleyFool.com
After Apple: Tech's Takeover of Healthcare Officially Begins
Sep 10 / MotleyFool.com
3 Best Stocks to Invest in Pharma
Sep 19 / MotleyFool.com
Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - An...
Sep 10 / Zacks.com
Gilead Down on Weak Simtuzumab Data and Sovaldi News - Analyst Blog
Sep 18 / Zacks.com
Roche's (RHHBY) RoActemra Gets EU Approval for Early RA - Analyst Blog
Sep 09 / Zacks.com
Europe struggles to catch US biotech bulls
Sep 18 / FT.com
Tax inversion makes a tempting M&A bet
Sep 08 / FT.com
Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?
Sep 18 / MotleyFool.com
Meet the new boss, same as the boss we started with
Sep 05 / FT.com
Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog
Sep 17 / Zacks.com
Levinson move highlights Google health ambitions
Sep 04 / FT.com
3 Stocks Pushing The Health Care Sector Higher
Sep 17 / TheStreet.com
Should there be a new Buffett rule?
Aug 26 / CNNMoney.com
Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone
Sep 17 / Benzinga
Roche to buy InterMune for $8.3bn
Aug 26 / FT.com
Biogen/AbbVie Report Positive Data on MS Drug Zinbryta - Analyst Blog
Sep 15 / Zacks.com
Burger King buying Tim Hortons
Aug 26 / CNNMoney.com
Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog
Sep 15 / Zacks.com
Heating up: Burger King is latest in M&A frenzy
Aug 25 / CNNMoney.com
AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog
Sep 12 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.